NEWS 16 FEED & ADDITIVE MAGAZINE February 2025 Axitan Limited entered into a strategic partnership with QualiTech - a global manufacturer of animal nutrition, plant nutrition, and food ingredient products and services - for the development and distribution of certain novel endolysin products. Under the terms of the agreement, QualiTech will be the exclusive distributor for Axitan’s FORC3® product for the swine, ruminant and all poultry markets in North America, except broilers. Axitan stated it will continue to be the exclusive distributor for broilers. FORC3® is a proven solution with unparallelled results in targeting Clostridium perfringens, the causative agent of necrotic enteritis in poultry. In addition to distributing FORC3® in North America, Axitan and QualiTech are collaborating to develop novel endolysin-based products to resolve pathogenic issues in the swine & ruminant segments. QualiTech will have the exclusive distribution rights of these new products for the swine & ruminant markets in North America. “Endolysins open the doorway to the next generation of antibiotic-free production. We are delighted to have entered into this agreement with QualiTech. It is a major endorsement for our technology platform and allows us to leverage QualiTech’s leading presence in the North American animal nutrition market,” said Alfred Zimmerman, CEO of Axitan. Since its formation, Axitan’s biotech team has pioneered the development and incorporation of endolysins into animal feed for targeting and eliminating pathogens historically managed through antibiotics. According to the company’s announcement, Axitan identifies and formulates endolysins into nutrient rich feed additives that help provide material performance benefits to livestock farmers in addition to pathogen mitigation. Read more>> Axitan and QualiTech form strategic partnership for antibiotic-free feed Intelligent nutrition company Novus International, Inc. entered a strategic co-development partnership with innovative biotechnology company Resilient Biotics to create a novel feed solution that supports immune health and helps reduce the risk of respiratory challenges in pigs. “Respiratory challenges like porcine reproductive and respiratory syndrome (PRRS), porcine respiratory disease complex (PRDC), and others create a strain on pig health and cost the industry billions each year in production loss. The industry eagerly wants to find unique ways to optimize pig health and impact the risk of these challenges,” says Gaurav Shah, Novus Associate Director of Innovation and Business Development. “Novus and Resilient Biotics are working to address these challenges in a way that hasn’t been done before. We’re very excited to work with Resilient Biotics to develop a new kind of feed solution that can make a huge impact on the swine industry.” “Resilient Biotics is excited to partner with Novus to bring novel microbial solutions to the market. The joint development effort will leverage Resilient Biotics’ deep knowledge of the swine respiratory microbiome and proven discovery platform to identify proprietary swine microbials that improve host health and boost defense against respiratory pathogens,” states Chris Belnap, Resilient Biotics CEO and Co-founder. Read more>> Novus, Resilient Biotics join forces for novel feed solution
RkJQdWJsaXNoZXIy MTUxNjkxNQ==